Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
NCT07075120
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma (HCC)
Interventions
DRUG:
Ipilimumab and Nivolumab
RADIATION:
Stereotactic Body Radiotherapy (SBRT)
Sponsor
University of Hawaii